Log in to save to my catalogue

Recent advances of bispecific antibodies in solid tumors

Recent advances of bispecific antibodies in solid tumors

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0b9e11158e4543168ed23f83ed3d707a

Recent advances of bispecific antibodies in solid tumors

About this item

Full title

Recent advances of bispecific antibodies in solid tumors

Publisher

England: BioMed Central Ltd

Journal title

Journal of hematology and oncology, 2017-09, Vol.10 (1), p.155-155, Article 155

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Cancer immunotherapy is the most exciting advancement in cancer therapy. Similar to immune checkpoint blockade and chimeric antigen receptor T cell (CAR-T), bispecific antibody (BsAb) is attracting more and more attention as a novel strategy of antitumor immunotherapy. BsAb not only offers an effective linkage between therapeutics (e.g., immune eff...

Alternative Titles

Full title

Recent advances of bispecific antibodies in solid tumors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_0b9e11158e4543168ed23f83ed3d707a

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0b9e11158e4543168ed23f83ed3d707a

Other Identifiers

ISSN

1756-8722

E-ISSN

1756-8722

DOI

10.1186/s13045-017-0522-z

How to access this item